Caspofungin: A potential cause of reversible severe thrombocytopenia

Pharmacotherapy

Volumn 24, Issue 10 II, 2004, Pages 1408-1411

  Lynch, Julia ^a   Wong Beringer, Annie ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Antifungal; Caspofungin; Echinocandins; Thrombocytopenia

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CREATININE; FLUCONAZOLE; FLUCYTOSINE; HEPARIN; IMMUNOGLOBULIN;

AGED; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ENDOCARDITIS; HUMAN; MALE; NEPHROTOXICITY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

AGED; ANTIFUNGAL AGENTS; CANDIDIASIS; ENDOCARDITIS; HUMANS; MALE; PEPTIDES, CYCLIC; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 4644276216     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.24.14.1408.43148     Document Type: Article

References (12)

1. Wong-Beringer A, Kriengkauykiat J. Systemic antifungal therapy: new options, new challenges. Pharmacotherapy 2003;23:1441-62.
2. Vermes A, Guchelaar HJ, Dankert J. Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 2000;46:171-9.
3. Vermes A, Mathot RAA, van der Sijs IH, Dankert J, Guchelaar HJ. Population pharmacokinetics of flucytosine: comparison and validation of three models using STS, NPEM, and NONMEM. Ther Drag Monitoring 2000;22:676-87.
4. Warkentin TE, Sheppard JI, Horsewood P, Simpson PJ, Moore JC, Kelton JG. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000;96:1703-8.
5. Chan CSP, Tuazon CU, Lessin SL. Amphotericin B-induced thrombocytopenia. Ann Intern Med 1982;96(3):332-3.
6. Elan Pharmaceuticals, Inc. Abelcet (amphotericin B lipid complex) package insert. San Diego, CA; June 2002.
7. Charak BS, Iyer RS, Rajoor BG, Saikia TK, Gopal R, Advani SH. Amphotericin B-related thrombocytopenia: a report of two cases. J Assoc Physicians India 1990;38:235-6.
8. Wilson R, Feldman S. Toxicity of amphotericin B in children with cancer. Am J Dis Child 1979;133:731-4.
9. Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis 2003;36:1445-57.
10. Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002;347:2020-9.
11. Merck & Co., Inc. Cancidas (caspofungin) package insert. Whitehouse Station, NJ; January 2003.
12. Bachmann SP, VandeWalle K, Ramage G, et al. In vitro activity of caspofungin against C. albicans biofilms. Antimicrob Agents Chemother 2002;46:3591-6.